<?xml version="1.0" encoding="UTF-8" standalone="yes"?>
<References xsi:schemaLocation="http://www.iedb.org/schema/CurationSchema http://beta.iedb.org/schema/Curation.xsd" xmlns="http://www.iedb.org/schema/CurationSchema" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
    <Reference>
        <ReferenceId>335</ReferenceId>
        <DateLastUpdated>2020-09-10-07:00</DateLastUpdated>
        <Article>
            <PubmedId>12121653</PubmedId>
            <Abstract>IL-10 is a dimeric cytokine that must engage its high-affinity cell surface receptor, IL-10R1, to induce multiple cellular activities. Here we report the 1.9 A crystal structure of an engineered IL-10 monomer (IL-10M1) in complex with a neutralizing Fab fragment (9D7Fab). 9D7Fab and IL-10R1 bind distinct nonoverlapping surfaces on IL-10M1. Antagonism of the IL-10M1/IL-10R1 interaction is the result of 9D7Fab-induced conformational changes in the CD loop of IL-10M1 that indirectly alter the structure of the IL-10R1 binding site. A single mutation (Ile87Ala) in the same CD loop region of the Epstein-Barr virus IL-10 (ebvIL-10) also reduces IL-10R1 binding affinity, suggesting that ebvIL-10 and 9D7Fab use similar allosteric mechanisms to modulate IL-10R1 affinity and biological activity.</Abstract>
            <ArticleYear>2002</ArticleYear>
            <ArticlePages>981-7</ArticlePages>
            <ArticleTitle>Noncompetitive antibody neutralization of IL-10 revealed by protein engineering and x-ray crystallography.</ArticleTitle>
            <Authors>
                <Author>
                    <LastName>Josephson</LastName>
                    <ForeName>Kristopher</ForeName>
                </Author>
                <Author>
                    <LastName>Jones</LastName>
                    <ForeName>Brandi C</ForeName>
                </Author>
                <Author>
                    <LastName>Walter</LastName>
                    <ForeName>Leigh J</ForeName>
                </Author>
                <Author>
                    <LastName>DiGiacomo</LastName>
                    <ForeName>Ruth</ForeName>
                </Author>
                <Author>
                    <LastName>Indelicato</LastName>
                    <ForeName>Stephen R</ForeName>
                </Author>
                <Author>
                    <LastName>Walter</LastName>
                    <ForeName>Mark R</ForeName>
                </Author>
            </Authors>
            <Affiliations>Center for Biophysical Sciences and Engineering, University of Alabama, Birmingham, 35294, USA.</Affiliations>
            <ArticleChemicalList>Immunoglobulin Fab Fragments;Receptors, Interleukin;Receptors, Interleukin-10;Interleukin-10</ArticleChemicalList>
            <ArticleMeshHeadingsList>Allosteric Regulation; Crystallography, X-Ray; Herpesvirus 4, Human(chemistry); Immunoglobulin Fab Fragments(chemistry); Interleukin-10(chemistry; genetics); Models, Molecular; Mutation; Protein Conformation; Protein Engineering; Receptors, Interleukin(chemistry); Receptors, Interleukin-10</ArticleMeshHeadingsList>
            <Journal>
                <Volume>10</Volume>
                <Issue>7</Issue>
                <Title>Structure (London, England)</Title>
                <Issn>0969-2126</Issn>
                <MedlineTa>Structure</MedlineTa>
            </Journal>
        </Article>
        <Epitopes>
            <Epitope>
                <EpitopeName>Fab 9D7 epitope on IL-10M1</EpitopeName>
                <EpitopeStructure>
                    <DiscontinuousRegionOnAccessionSequenceMolecule>
                        <ChemicalType>Discontinuous protein residues</ChemicalType>
                        <DiscontinuousResidues>F89, Y90, L91, E92, E93, V94, M95, P96, Q97, A98, E99, N100, Q101, K143, N144, A145, F146, N147, K148, L149, Q150, E151, K152, G153, I154, Y155</DiscontinuousResidues>
                        <SourceMolecule>
                            <GenBankId>P22301.1</GenBankId>
                        </SourceMolecule>
                        <SourceOrganismId>9606</SourceOrganismId>
                    </DiscontinuousRegionOnAccessionSequenceMolecule>
                </EpitopeStructure>
                <LocationOfData>Figure 1</LocationOfData>
                <EpitopeId>122245</EpitopeId>
                <ReferenceRegion>F71, Y72, L73, E74, E75, V76, M77, P78, Q79, A80, E81, N82, Q83, K125, N126, A127, F128, N129, K130, L131, Q132, E133, K134, G135, I136, Y137</ReferenceRegion>
                <EpitopeEvidenceCode>Representative selection</EpitopeEvidenceCode>
                <EpitopeStructureDefines>Exact Epitope</EpitopeStructureDefines>
                <Assays>
                    <BCell>
                        <LocationOfData>Figure 4</LocationOfData>
                        <BCellId>1708384</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10116</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P22301.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization is reported in Abrams et al., Immunol Rev. 1992 127: 5-24 [PMID: 1387110]. No details are provided.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>316</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <AssayComments>The epitope-specific 9D7 Fab inhibited the binding of IL-10M1 to the receptor IL-10R1, as measured by isothermal calorimetry titration. Fab 9D7 and IL-10R1 bind distinct nonoverlapping sites on IL-10, and the authors show that its neutralization is due to an allosteric mechanism, where the Fab induces conformational changes that indirectly disrupt the IL-10R1 binding site. The antigen IL-10M1 is the “unswapped” monomer of IL-10 and was created by inserting six residues (GGGSGG) between Asn134 and Lys135 of the IL-10 DE loop.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>9D7</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>9D7</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1LK3_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10116</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1LK3_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10116</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>IL-10M1</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P22301.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                    </BCell>
                </Assays>
                <Assays>
                    <BCell>
                        <LocationOfData>Table 1, Figure 1 and PDB 1LK3</LocationOfData>
                        <BCellId>1491355</BCellId>
                        <Immunization>
                            <HostOrganism>
                                <OrganismId>10116</OrganismId>
                            </HostOrganism>
                            <FirstInVivoProcess>
                                <InVivoProcessType>Administration in vivo</InVivoProcessType>
                                <ImmunogenObject>
                                    <EpitopeRelation>Source Antigen</EpitopeRelation>
                                    <Object>
                                        <AccessionSequenceMolecule>
                                            <ChemicalType>Protein</ChemicalType>
                                            <Molecule>
                                                <GenBankId>P22301.1</GenBankId>
                                            </Molecule>
                                            <SourceOrganismId>9606</SourceOrganismId>
                                        </AccessionSequenceMolecule>
                                    </Object>
                                </ImmunogenObject>
                                <ImmunogenEvidenceCode>Representative selection</ImmunogenEvidenceCode>
                            </FirstInVivoProcess>
                            <ImmunizationComments>Immunization is reported in Abrams et al., Immunol Rev. 1992 127: 5-24 [PMID: 1387110]. No details are provided.</ImmunizationComments>
                        </Immunization>
                        <AssayInformation>
                            <AssayTypeId>436</AssayTypeId>
                            <QualitativeMeasurement>Positive</QualitativeMeasurement>
                            <QuantitativeMeasurement>1.9</QuantitativeMeasurement>
                            <MeasurementInequality>=</MeasurementInequality>
                            <AssayComments>The epitope of Fab 9D7 on IL-10M1 was determined from the crystal structure of the complex, solved by molecular replacement. There are two complexes in the asymmetric unit. The antigen IL-10M1 is the “unswapped” monomer of IL-10 and was created by inserting six residues (GGGSGG) between Asn134 and Lys135 of the IL-10 DE loop. Residues at the N and C termini (S26-P38 and I176-N178) and the added residues at the DE loop were not visible in the electron density.</AssayComments>
                        </AssayInformation>
                        <AssayedAntibody>
                            <AssayedAntibodySourceMaterial>Purified Immunoglobulin</AssayedAntibodySourceMaterial>
                            <AssayedAntibodyImmunoglobulinDomain>Fab</AssayedAntibodyImmunoglobulinDomain>
                            <AssayedAntibodyPurificationStatus>Monoclonal</AssayedAntibodyPurificationStatus>
                            <AssayedAntibodyName>9D7</AssayedAntibodyName>
                            <AssayedAntibodyHeavyChainType>IgG1</AssayedAntibodyHeavyChainType>
                            <AssayedAntibodyLightChainType>Kappa</AssayedAntibodyLightChainType>
                            <AssayedAntibodyObject>
                                <MultiChainMolecule>
                                    <ChemicalType>Multi-Chain protein</ChemicalType>
                                    <MoleculeName>9D7</MoleculeName>
                                    <Chain1>
                                        <Molecule>
                                            <GenBankId>1LK3_H</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10116</SourceOrganismId>
                                    </Chain1>
                                    <Chain2>
                                        <Molecule>
                                            <GenBankId>1LK3_L</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>10116</SourceOrganismId>
                                    </Chain2>
                                </MultiChainMolecule>
                            </AssayedAntibodyObject>
                        </AssayedAntibody>
                        <Antigen>
                            <AntigenReferenceName>IL-10M1</AntigenReferenceName>
                            <AntigenConformation>Native</AntigenConformation>
                            <AntigenObject>
                                <EpitopeRelation>Source Antigen</EpitopeRelation>
                                <Object>
                                    <AccessionSequenceMolecule>
                                        <ChemicalType>Protein</ChemicalType>
                                        <Molecule>
                                            <GenBankId>P22301.1</GenBankId>
                                        </Molecule>
                                        <SourceOrganismId>9606</SourceOrganismId>
                                    </AccessionSequenceMolecule>
                                </Object>
                            </AntigenObject>
                            <AntigenEvidenceCode>Representative selection</AntigenEvidenceCode>
                        </Antigen>
                        <ThreeDimensionalStructureOfComplex>
                            <ComplexPdbId>1LK3</ComplexPdbId>
                            <AntibodyChain1PdbChain>H</AntibodyChain1PdbChain>
                            <AntibodyChain2PdbChain>L</AntibodyChain2PdbChain>
                            <AntigenChainPdbChain>A</AntigenChainPdbChain>
                            <ViewerFlag>Y</ViewerFlag>
                            <Comments>The antigen residues E75, N82, Q83, E133 form hydrogen bonds with the Fab. All the six CDR loops interact with the antigen. Fab light chain's N-terminal residue D1 forms salt bridge with the antigen K130. Comparison of this Fab/IL-10M1 complex with free [PDB: 2ILK] and sIL-10R1-bound [PDB: 1J7V] IL-10 shows that Fab binding induces conformational changes in the antigen residues 38-44, helix F residue Y137 and CD loop residues Q83, D84, P85, and D86 -- residues critical for the IL-10R1 binding.</Comments>
                            <CuratedContacts>
                                <EpitopeResidues>A: F71, Y72, L73, E74, E75, V76, M77, P78, Q79, A80, E81, N82, Q83, K125, N126, A127, F128, N129, K130, L131, Q132, E133, K134, G135, I136, Y137;</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: Y33:H1, Y50:H2, N52:H2, S55:H2, Y57:H2, N59:H2, P101:H3, G102:H3, N103:H3, N104:H3; L: D1, R31:L1, K49:L2, S90:L3, W91:L3, G93:L3;</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>808.0</ContactAreaForAntigen>
                                <ContactAreaForAntibody>753.0</ContactAreaForAntibody>
                            </CuratedContacts>
                            <CalculatedContacts>
                                <EpitopeResidues>A: M39, F71, E74, E75, P78, Q79, N82, Q83, K125, F128, N129, K130, L131, Q132, E133, K134, I136, Y137</EpitopeResidues>
                                <AntibodyResiduesInteractingWithAntigen>H: Y33, W47, Y50, N52, S55, Y57, T58, N59, V100, P101, G102, N103, N104, W105; L: D1, R31, K49, S90, W91, N92, G93, P94, L95</AntibodyResiduesInteractingWithAntigen>
                                <ContactAreaForAntigen>827.3</ContactAreaForAntigen>
                                <ContactAreaForAntibody>782.3</ContactAreaForAntibody>
                            </CalculatedContacts>
                        </ThreeDimensionalStructureOfComplex>
                    </BCell>
                </Assays>
            </Epitope>
        </Epitopes>
    </Reference>
</References>

